Cancer researchers have discovered a previously unknown type of gene regulation and DNA behavior in breast cancer cells that may lead to better insight about environmental exposure to estrogen-like compounds.
Nearly three-quarters of Americans are confident in our system for reviewing the effectiveness and safety of new medicines and medical devices, yet 41% say it takes too long to approve a drug and allow it to be sold to consumers. ...
Since the discovery of gene sequencing in the late 1970s, it was predicted that genetics would revolutionise medicine and provide answers to the causes of many of our common killers. But has genetic research delivered its ...
Changes are urgently needed to end the secrecy surrounding approval of new drugs in Europe, argue experts in the British Medical Journal today.
After a decade of remarkable growth, total annual funding for biomedical research in the U.S. has decelerated and may have even fallen when adjusted for inflation. That is the conclusion of a study today published in the ...
Can we trust the results of research done on children?
In BMJ today two experts debate whether the conflict of interest is unacceptable when drug companies carry out clinical trials on their own medicines.
If you feel like you're in a losing battle with a triple-chocolate cake, a "mental budget" can help, according to a new study in the Journal of Consumer Research.
Can social networking sites help people make wise health decisions? A new study in the Journal of Consumer Research says it depend on people's willingness to take action on the information they gain from the sites.
Fears that medical research using tissue such as blood or material from biopsies would be obstructed by the Human Tissue Act 2004 may have been unfounded, a new study from the University of Leicester reveals.